Legal status
Legal status
  • N-({2-[1-(5-fluoropentyl)-1H-indol-3-yl]-1,3-thiazol-4-yl}methyl)-2-methoxy-N-methylethanamine
PubChem CID
Chemical and physical data
Molar mass389.53 g·mol−1
3D model (JSmol)
  • COCCN(C)Cc1csc(n1)c1cn(CCCCCF)c2ccccc21
  • InChI=1S/C21H28FN3OS/c1-24(12-13-26-2)14-17-16-27-21(23-17)19-15-25(11-7-3-6-10-22)20-9-5-4-8-18(19)20/h4-5,8-9,15-16H,3,6-7,10-14H2,1-2H3

PTI-3 is an indole-3-thiazole based synthetic cannabinoid which has been sold as a designer drug.[1] It was first identified in Hungary in 2020,[2] and was made illegal in Italy in June 2021.[3]

See also


  1. ^ Malaca S, Tini A, Umani Ronchi F (January 2022). "Fourth generation of synthetic cannabinoid receptor agonists: a summary on the latest insights". Acta Bio-Medica. 92 (6): e2021546. doi:10.23750/abm.v92i6.12696. PMC 8823589. PMID 35075053.
  2. ^ European Monitoring Center for Drugs and Drug Addiction (December 2020). New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic. An update from the EU Early Warning System (PDF). Luxembourg: Publications Office of the European Union. doi:10.2810/921262. ISBN 9789294975584.
  3. ^ "Decreto 1 Giugno 2021. Aggiornamento delle tabelle contenenti l'indicazione delle sostanze stupefacenti e psicotrope, di cui al decreto del Presidente della Repubblica 9 ottobre 1990, n. 309 e successive modificazioni e integrazioni. Inserimento nella tabella I di nuove sostanze psicoattive. (21A03590) (GU Serie Generale n.144 del 18-06-2021)" [Decree of 1 June 2021. Update of the tables containing the indication of narcotic and psychotropic substances, as per the decree of the President of the Republic of 9 October 1990, n. 309 and subsequent amendments and additions. Inclusion in Table I of new psychoactive substances. (21A03590) (GU General Series n.144 of 18-06-2021] (in Italian).